Literature DB >> 16303975

Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death.

Shin-Ichi Manabe1, Zezong Gu, Stuart A Lipton.   

Abstract

PURPOSE: Understanding the mechanism of neuronal cell death in retinal diseases like glaucoma is important for devising new treatments. One factor involves excitatory amino acid stimulation of N-methyl-D-aspartate (NMDA)-type glutamate receptors, excessive Ca2+ influx, and formation of nitric oxide (NO) via neuronal NO synthase (nNOS). Another factor is the abnormal activation of matrix metalloproteinases (MMPs), in particular MMP-9, which triggers an extracellular signaling cascade leading to apoptosis. This study was designed to investigate the mechanism of excitotoxic retinal ganglion cell (RGC) death in vivo and its relationship to MMP activation.
METHODS: NMDA and glycine were injected into the vitreous of the eye in rats and in nNOS-deficient mice (nNOS-/-) versus control. Gelatinolytic activity of MMP-9 and MMP-2 by zymography and cellular localization by immunohistochemistry were examined, and the effect of MMP inhibition on NMDA-induced RGC death was tested.
RESULTS: NMDA was found to upregulate the proform of MMP-9 in the retina and to increase MMP-9 gelatinolytic activity. Retrograde labeling with aminostilbamidine to identify RGCs confirmed that MMP activity occurred only in these retinal neurons and not in glial or other retinal cell types after excitotoxic insult. Deconvolution fluorescence microscopy revealed that MMP activity colocalized with immunoreactive S-nitrosylated protein. NMDA-induced MMP activation was diminished in the retina of nNOS-/- mice, implying that S-nitrosylation of MMP had indeed occurred. In addition, the broad-spectrum MMP inhibitor GM6001 protected RGCs after intravitreal NMDA injection.
CONCLUSIONS: These findings suggest that an extracellular proteolytic pathway in the retina contributes to RGC death via NO-activated MMP-9.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303975     DOI: 10.1167/iovs.05-0128

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  47 in total

1.  Nitric oxide potentiates TNF-α-induced neurotoxicity through suppression of NF-κB.

Authors:  Atsuko Nakaizumi; Taeko Horie; Teruyo Kida; Takuji Kurimoto; Tetsuya Sugiyama; Tsunehiko Ikeda; Hidehiro Oku
Journal:  Cell Mol Neurobiol       Date:  2011-07-21       Impact factor: 5.046

2.  Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury.

Authors:  Huaqing Liu; Veronica I Shubayev
Journal:  Exp Neurol       Date:  2011-07-02       Impact factor: 5.330

3.  Matrix metalloproteinase 9 expression: new regulatory elements.

Authors:  Irina Surgucheva; Kumaravel Chidambaram; David A Willoughby; Andrei Surguchov
Journal:  J Ocul Biol Dis Infor       Date:  2010-08-05

4.  Matrix metalloproteinase inhibition enhances the rate of nerve regeneration in vivo by promoting dedifferentiation and mitosis of supporting schwann cells.

Authors:  Huaqing Liu; Youngsoon Kim; Sharmila Chattopadhyay; Igor Shubayev; Jennifer Dolkas; Veronica I Shubayev
Journal:  J Neuropathol Exp Neurol       Date:  2010-04       Impact factor: 3.685

5.  Light-evoked S-nitrosylation in the retina.

Authors:  Ryan E Tooker; Jozsef Vigh
Journal:  J Comp Neurol       Date:  2015-05-12       Impact factor: 3.215

6.  Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch.

Authors:  Sean M McCarthy; Peter F Bove; Dwight E Matthews; Takaaki Akaike; Albert van der Vliet
Journal:  Biochemistry       Date:  2008-05-02       Impact factor: 3.162

7.  MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Authors:  Hideo Kobayashi; Sharmila Chattopadhyay; Kinshi Kato; Jennifer Dolkas; Shin-Ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  Mol Cell Neurosci       Date:  2008-09-05       Impact factor: 4.314

8.  Mmp-9, a potential target for cerebral ischemic treatment.

Authors:  Xue Dong; Yu-Ning Song; Wei-Guo Liu; Xiu-Li Guo
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 9.  Aberrant protein s-nitrosylation in neurodegenerative diseases.

Authors:  Tomohiro Nakamura; Shichun Tu; Mohd Waseem Akhtar; Carmen R Sunico; Shu-Ichi Okamoto; Stuart A Lipton
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

10.  Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model.

Authors:  Edward M Barnett; Xu Zhang; Dustin Maxwell; Qing Chang; David Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.